Release Date: 12-Jul-2024
Bispecific antibodies, a promising class of immunotherapeutics, bind to two different antigens simultaneously, enhancing their specificity and efficacy. They offer diverse therapeutic strategies, including redirecting immune cells to tumors, dual targeting of tumor antigens or modulating immune cell interactions. Clinical trials have shown their potential in treating various cancers, autoimmune diseases, and infectious diseases. Despite challenges like manufacturing complexity and immunogenicity, recent advancements in engineering and design have accelerated their development. Bispecific antibodies hold immense promise in revolutionizing treatment paradigms, with ongoing research focusing on optimizing their pharmacokinetics, safety profiles and therapeutic applications across a spectrum of diseases.
Download Report:
https://www.kuickresearch.com/report-bispecific-antibody-market-bispecific-antibodies-market